Filters
Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar ...
Press Release, Product
Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA
Press Release, Corporate
Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to...
Press Release, Corporate
Hikma continues strong 2021 performance and reiterates full year guidance
Press Release, Corporate
Hikma and Almirall enter an exclusive licensing agreement to market Finjuve in the Middle East and North Africa region
Press Release, Product
Hikma donates 50,000 doses of injectable naloxone to help expand non-profit access to lifesaving treatment for reversing...
Press Release, Corporate
Hikma launches Micafungin for Injection
Press Release, Product
Hikma strengthens US Injectables business through acquisition of Custopharm
Press Release, Inside Information
REMINDER Generics Meet the Management 23 September 2021, 2:00pm to 3:15pm
Press Release, Corporate
Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the US
Press Release, Product
Bio-Thera Solutions and Hikma Pharmaceuticals announce exclusive commercialization and license agreement for BAT2206 in ...
Press Release, Corporate
Meet the Management Series – Generics
Press Release, Corporate
Hikma delivers another strong financial and operational performance and improves FY outlook for Generics
Press Release, Corporate
Hikma announces US launch of KLOXXADOTM (naloxone HCl) nasal spray 8mg
Press Release, Product
